PMDA drug package insert
バファリン配合錠A81
PMDA Prescription drug · ライオン株式会社 · package insert Jan 13, 2026
Key facts
| Brand names | バファリン配合錠A81 |
|---|---|
| Nonproprietary names | アスピリン・ダイアルミネート |
| Companies | 製造販売元／ライオン株式会社, 販売元／エーザイ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗血小板剤 |
| Therapeutic category codes | 873399 |
| YJ codes | 3399100F1116 |
| Approval numbers | 22100AMX01376000 |
| Package insert edition | 第5版 |
| Package insert date | Jan 13, 2026 |
| PMDA document key | 840001_3399100F1116_1 |
| PMDA company code | 840001 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: